New York State Common Retirement Fund
ANIK icon

New York State Common Retirement Fund’s Anika Therapeutics ANIK Stock Holding History

New York State Common Retirement Fund’s Portfolio ANIK Stock Details ANIK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$50.1K Hold
3,423
– – ﹤0.01% 3014
2026
Q1 		$49.6K Hold
3,423
– – ﹤0.01% 2820
2025
Q4 		$32.9K Hold
3,423
– – ﹤0.01% 3011
2025
Q3 		$32.2K Hold
3,423
– – ﹤0.01% 3045
2025
Q2 		$36.2K Hold
3,423
– – ﹤0.01% 3023
2025
Q1 		$51.4K Hold
3,423
– – ﹤0.01% 2761
2024
Q4 		$56.3K Hold
3,423
– – ﹤0.01% 2824
2024
Q3 		$84.5K Sell
3,423
-3,900
-53% -$101K ﹤0.01% 2667
2024
Q2 		$185K Buy
7,323
+5
+0.1% +$130 ﹤0.01% 2463
2024
Q1 		$186K Sell
7,318
-6
-0.1% -$145 ﹤0.01% 2473
2023
Q4 		$166K Sell
7,324
-34
-0.5% -$704 ﹤0.01% 2542
2023
Q3 		$137K Buy
7,358
+44
+0.6% +$912 ﹤0.01% 2583
2023
Q2 		$190K Buy
7,314
+77
+1% +$2.06K ﹤0.01% 2523
2023
Q1 		$208K Sell
7,237
-3,988
-36% -$119K ﹤0.01% 2568
2022
Q4 		$332K Sell
11,225
-6
-0.1% -$171 ﹤0.01% 2513
2022
Q3 		$267K Buy
11,231
+33
+0.3% +$759 ﹤0.01% 2640
2022
Q2 		$250K Sell
11,198
-35
-0.3% -$781 ﹤0.01% 2691
2022
Q1 		$282K Buy
11,233
+15
+0.1% +$457 ﹤0.01% 2673
2021
Q4 		$402K Sell
11,218
-1,328
-11% -$53.2K ﹤0.01% 2548
2021
Q3 		$534K Buy
12,546
+29
+0.2% +$1.19K ﹤0.01% 2425
2021
Q2 		$542K Buy
12,517
+117
+0.9% +$4.98K ﹤0.01% 2559
2021
Q1 		$506K Hold
12,400
– – ﹤0.01% 2456
2020
Q4 		$561K Sell
12,400
-2,700
-18% -$102K ﹤0.01% 2301
2020
Q3 		$534K Hold
15,100
– – ﹤0.01% 2181
2020
Q2 		$570K Buy
15,100
+3,000
+25% +$98.8K ﹤0.01% 2139
2020
Q1 		$350K Hold
12,100
– – ﹤0.01% 2209
2019
Q4 		$627K Sell
12,100
-1,800
-13% -$105K ﹤0.01% 2175
2019
Q3 		$763K Sell
13,900
-100
-0.7% -$5.13K ﹤0.01% 2115
2019
Q2 		$569K Hold
14,000
– – ﹤0.01% 2310
2019
Q1 		$423K Hold
14,000
– – ﹤0.01% 2383
2018
Q4 		$471K Sell
14,000
-2,900
-17% -$105K ﹤0.01% 2311
2018
Q3 		$713K Sell
16,900
-2,090
-11% -$82.6K ﹤0.01% 2271
2018
Q2 		$608K Hold
18,990
– – ﹤0.01% 2367
2018
Q1 		$944K Buy
18,990
+2,090
+12% +$118K ﹤0.01% 2054
2017
Q4 		$911K Buy
16,900
+1,500
+10% +$83K ﹤0.01% 2089
2017
Q3 		$893K Hold
15,400
– – ﹤0.01% 2062
2017
Q2 		$760K Sell
15,400
-1
-0% -$46 ﹤0.01% 2199
2017
Q1 		$669K Sell
15,401
-2,739
-15% -$131K ﹤0.01% 2237
2016
Q4 		$888K Sell
18,140
-42,420
-70% -$1.96M ﹤0.01% 2104
2016
Q3 		$2.9M Buy
60,560
+10,055
+20% +$497K ﹤0.01% 1478
2016
Q2 		$2.71M Buy
50,505
+35,105
+228% +$1.65M ﹤0.01% 1495
2016
Q1 		$689K Sell
15,400
-38,590
-71% -$1.57M ﹤0.01% 2123
2015
Q4 		$2.06M Sell
53,990
-69,591
-56% -$2.66M ﹤0.01% 1587
2015
Q3 		$3.93M Sell
123,581
-16,496
-12% -$575K 0.01% 1307
2015
Q2 		$4.63M Buy
140,077
+20,791
+17% +$742K 0.01% 1398
2015
Q1 		$4.91M Buy
119,286
+79,763
+202% +$3.22M 0.01% 1221
2014
Q4 		$1.61M Buy
39,523
+14,242
+56% +$557K ﹤0.01% 1694
2014
Q3 		$927K Sell
25,281
-41,825
-62% -$1.81M ﹤0.01% 1879
2014
Q2 		$3.11M Sell
67,106
-74,150
-52% -$3.3M ﹤0.01% 1475
2014
Q1 		$5.81M Buy
141,256
+59,725
+73% +$2.22M 0.01% 1162
2013
Q4 		$3.11M Buy
+81,531
New +$2.52M ﹤0.01% 1433

Other funds holding ANIK

CM
Capital Management Glen Allen, Virginia $666M AUM 17.17% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.94% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
CWP
Curated Wealth Partners El Segundo, California $774M AUM 5.71% 1-Year Est. Return
SO
STRS Ohio Columbus, Ohio $26.7B AUM 43.32% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.12B AUM 34.21% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return

New York State Common Retirement Fund's ANIK Position: Q2 2026 in Review

New York State Common Retirement Fund held its Anika Therapeutics (ANIK) position steady in Q2 2026 at 3,423 shares worth $50.1K. The position accounts for ﹤0.01% of the portfolio, ranked #3014.

New York State Common Retirement Fund first reported a position in ANIK in Q4 2013 and has held it in 51 quarters since. The position peaked at $5.81M in Q1 2014. 26 funds tracked by Wall St. Rank hold ANIK as of Q2 2026.

  • New York State Common Retirement Fund held 3,423 shares of Anika Therapeutics worth $50.1K as of Q2 2026.
  • New York State Common Retirement Fund left its Anika Therapeutics share count unchanged in Q2 2026.
  • Anika Therapeutics made up ﹤0.01% of New York State Common Retirement Fund's portfolio in Q2 2026, its #3014 holding.
  • New York State Common Retirement Fund first reported a position in Anika Therapeutics in Q4 2013 and has held it in 51 quarters since.
  • New York State Common Retirement Fund's Anika Therapeutics position peaked at $5.81M in Q1 2014.
  • 26 funds tracked by Wall St. Rank held Anika Therapeutics as of Q2 2026.

Based on New York State Common Retirement Fund's 13F filing for Q2 2026, filed 29 Jul 2026.